Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Jeffrey Swigris

Concepts (370)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
636
12.800
 Why?
Lung Diseases, Interstitial
57
2024
616
10.410
 Why?
Quality of Life
46
2024
2704
6.670
 Why?
Pulmonary Fibrosis
25
2024
386
5.780
 Why?
Dyspnea
27
2024
242
5.360
 Why?
Cough
10
2024
115
3.840
 Why?
Oxygen Inhalation Therapy
13
2021
143
3.720
 Why?
Surveys and Questionnaires
37
2024
5401
3.080
 Why?
Vital Capacity
32
2024
292
2.990
 Why?
Connective Tissue Diseases
13
2019
82
2.430
 Why?
Alveolitis, Extrinsic Allergic
6
2024
98
1.980
 Why?
Arthritis, Rheumatoid
12
2024
1092
1.880
 Why?
Lymphangioleiomyomatosis
6
2024
34
1.850
 Why?
Pyridones
12
2023
159
1.800
 Why?
Patient Reported Outcome Measures
7
2024
372
1.710
 Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
339
1.590
 Why?
Indoles
6
2024
387
1.550
 Why?
Patient Outcome Assessment
3
2021
125
1.490
 Why?
Sarcoidosis
5
2021
156
1.450
 Why?
Humans
161
2025
129622
1.370
 Why?
Lung
21
2024
3931
1.330
 Why?
Severity of Illness Index
19
2024
2742
1.320
 Why?
Aged
67
2025
22099
1.310
 Why?
Middle Aged
79
2025
31150
1.300
 Why?
Pulmonary Medicine
3
2022
79
1.300
 Why?
Fatigue
9
2024
318
1.280
 Why?
Walking
7
2013
501
1.190
 Why?
Respiratory Function Tests
18
2024
586
1.110
 Why?
Oxygen
7
2023
915
1.100
 Why?
Psychometrics
10
2022
691
1.070
 Why?
Patients
3
2018
167
1.050
 Why?
Male
88
2025
63674
1.010
 Why?
Health Care Costs
3
2018
367
1.010
 Why?
Hypertension, Pulmonary
6
2023
1894
1.000
 Why?
Research Design
5
2016
1043
0.980
 Why?
Female
91
2025
68770
0.980
 Why?
Exercise Test
9
2024
613
0.970
 Why?
Health Status Indicators
4
2014
167
0.960
 Why?
Activities of Daily Living
6
2022
383
0.940
 Why?
Patient-Centered Care
2
2021
505
0.920
 Why?
Reproducibility of Results
18
2024
3083
0.900
 Why?
Disease Progression
19
2024
2635
0.880
 Why?
Exercise Tolerance
4
2020
273
0.860
 Why?
Mycophenolic Acid
4
2016
110
0.790
 Why?
Caregivers
4
2019
815
0.790
 Why?
Tomography, X-Ray Computed
17
2025
2535
0.790
 Why?
Forced Expiratory Volume
12
2023
511
0.760
 Why?
Internet
2
2016
616
0.750
 Why?
Organizational Objectives
1
2021
73
0.730
 Why?
Patient Satisfaction
3
2021
633
0.720
 Why?
Nursing Research
1
2021
47
0.710
 Why?
Pulmonary Emphysema
2
2024
275
0.670
 Why?
Lactic Acid
1
2022
303
0.670
 Why?
Chronic Disease
5
2022
1720
0.650
 Why?
Symptom Assessment
1
2020
125
0.650
 Why?
Rhinitis, Allergic
1
2020
38
0.650
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.650
 Why?
Fatty Acids
1
2022
427
0.610
 Why?
Pulmonary Disease, Chronic Obstructive
4
2022
985
0.610
 Why?
Particulate Matter
1
2020
247
0.570
 Why?
Emphysema
1
2018
109
0.570
 Why?
Needs Assessment
2
2019
360
0.560
 Why?
Patient Education as Topic
3
2019
741
0.550
 Why?
Autoimmune Diseases
4
2019
426
0.550
 Why?
Aged, 80 and over
19
2021
7084
0.550
 Why?
Longitudinal Studies
9
2020
2716
0.540
 Why?
Lung Diseases
3
2015
742
0.530
 Why?
Qualitative Research
4
2017
1234
0.530
 Why?
Lung Transplantation
1
2019
289
0.520
 Why?
Pulmonary Diffusing Capacity
7
2019
74
0.510
 Why?
United States
25
2024
13900
0.510
 Why?
Treatment Outcome
20
2023
10226
0.510
 Why?
Heart Rate
2
2011
801
0.500
 Why?
Air Pollutants
1
2020
313
0.500
 Why?
Adult
39
2024
35572
0.500
 Why?
Exercise
4
2022
1924
0.490
 Why?
Immunosuppressive Agents
4
2016
853
0.490
 Why?
Information Seeking Behavior
1
2016
33
0.490
 Why?
Idiopathic Interstitial Pneumonias
6
2017
49
0.490
 Why?
Ambulatory Care
2
2018
504
0.490
 Why?
Gastroesophageal Reflux
2
2021
232
0.480
 Why?
Narration
1
2016
57
0.470
 Why?
Double-Blind Method
10
2024
1876
0.470
 Why?
Prognosis
15
2024
3794
0.470
 Why?
Mental Health
2
2020
686
0.460
 Why?
Telemedicine
1
2023
788
0.450
 Why?
Kaplan-Meier Estimate
8
2018
857
0.450
 Why?
Retrospective Studies
26
2025
14519
0.450
 Why?
Antibodies, Monoclonal
1
2021
1367
0.440
 Why?
Autoimmunity
2
2019
862
0.440
 Why?
Biomedical Research
2
2018
638
0.440
 Why?
Autoantibodies
6
2023
1466
0.430
 Why?
Lung Neoplasms
4
2024
2344
0.420
 Why?
Antitussive Agents
1
2013
7
0.420
 Why?
Social Media
1
2016
137
0.410
 Why?
Thalidomide
1
2013
32
0.410
 Why?
Bronchiolitis Obliterans
1
2013
68
0.400
 Why?
Social Support
2
2019
588
0.400
 Why?
Survival Rate
7
2019
1877
0.400
 Why?
Physicians
2
2019
864
0.400
 Why?
Motivation
1
2017
546
0.400
 Why?
Bronchial Diseases
1
2012
38
0.390
 Why?
Follow-Up Studies
9
2018
4896
0.380
 Why?
Patient Participation
1
2015
413
0.380
 Why?
Quality Indicators, Health Care
1
2014
298
0.360
 Why?
Scleroderma, Systemic
4
2019
114
0.360
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1279
0.360
 Why?
Oxygen Consumption
3
2022
672
0.360
 Why?
Health Status
5
2019
755
0.350
 Why?
Hospitalization
3
2017
2070
0.340
 Why?
Multivariate Analysis
5
2017
1502
0.340
 Why?
Peptides, Cyclic
1
2012
256
0.340
 Why?
Protein Kinase Inhibitors
3
2021
891
0.340
 Why?
Motor Activity
1
2014
676
0.330
 Why?
Endothelins
1
2010
62
0.330
 Why?
Cause of Death
6
2019
393
0.320
 Why?
Diagnosis, Differential
7
2019
1434
0.320
 Why?
Pulmonologists
2
2019
15
0.310
 Why?
Proportional Hazards Models
4
2019
1201
0.310
 Why?
Pulmonary Embolism
1
2011
211
0.310
 Why?
Amino Acyl-tRNA Synthetases
3
2016
30
0.300
 Why?
Asthma
2
2020
2230
0.300
 Why?
TRPP Cation Channels
1
2009
79
0.300
 Why?
Endothelin-1
1
2010
179
0.300
 Why?
Polycystic Kidney Diseases
1
2009
68
0.290
 Why?
Prospective Studies
9
2021
7131
0.290
 Why?
Palliative Care
3
2019
725
0.290
 Why?
Sleep Apnea, Obstructive
1
2012
273
0.280
 Why?
Cohort Studies
7
2024
5420
0.280
 Why?
Randomized Controlled Trials as Topic
5
2017
1367
0.270
 Why?
Sirolimus
2
2023
266
0.270
 Why?
Consensus
2
2024
615
0.270
 Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.270
 Why?
Exercise Therapy
3
2024
412
0.260
 Why?
Bronchoalveolar Lavage Fluid
2
2025
644
0.260
 Why?
Sex Distribution
3
2012
359
0.260
 Why?
Home Care Services
2
2020
246
0.260
 Why?
Biopsy
7
2016
1097
0.260
 Why?
Tumor Suppressor Proteins
1
2009
317
0.260
 Why?
Mortality
4
2019
307
0.260
 Why?
Prevalence
5
2018
2564
0.260
 Why?
Cost of Illness
3
2018
278
0.250
 Why?
Myositis
3
2019
51
0.250
 Why?
Patient Advocacy
2
2024
73
0.250
 Why?
Quality Improvement
1
2014
1101
0.240
 Why?
Lupus Erythematosus, Systemic
1
2008
247
0.240
 Why?
Thrombosis
1
2008
343
0.220
 Why?
Minimal Clinically Important Difference
2
2021
13
0.220
 Why?
Fibrosis
2
2024
520
0.220
 Why?
Time Factors
7
2019
6556
0.210
 Why?
Databases, Factual
3
2019
1269
0.210
 Why?
Age Distribution
3
2019
372
0.210
 Why?
Delphi Technique
1
2024
224
0.210
 Why?
Evidence-Based Medicine
2
2020
718
0.200
 Why?
Respiratory Therapy
2
2019
23
0.200
 Why?
Sex Factors
6
2019
1968
0.200
 Why?
Environmental Exposure
2
2020
463
0.200
 Why?
Receptors, Lysophosphatidic Acid
1
2021
30
0.190
 Why?
Patient Care Management
1
2021
56
0.180
 Why?
Incidence
3
2018
2644
0.180
 Why?
Registries
3
2019
1895
0.170
 Why?
Focus Groups
3
2016
453
0.170
 Why?
Analysis of Variance
3
2015
1288
0.170
 Why?
Survival Analysis
3
2017
1274
0.170
 Why?
Linear Models
3
2019
819
0.170
 Why?
Risk Factors
8
2021
9763
0.170
 Why?
Logistic Models
4
2019
1988
0.170
 Why?
Pain Measurement
1
2022
506
0.170
 Why?
Interleukin-13
1
2021
147
0.170
 Why?
Antibodies, Antinuclear
4
2016
66
0.170
 Why?
Walk Test
2
2017
70
0.170
 Why?
Sensitivity and Specificity
3
2015
1838
0.160
 Why?
Chi-Square Distribution
2
2011
516
0.160
 Why?
Allied Health Personnel
1
2019
41
0.150
 Why?
General Practitioners
1
2019
27
0.150
 Why?
Terminal Care
2
2019
237
0.150
 Why?
Lipid Metabolism
1
2022
497
0.150
 Why?
Insurance Claim Review
1
2018
64
0.150
 Why?
Immunoglobulin A
1
2019
200
0.150
 Why?
Anxiety
3
2019
965
0.150
 Why?
Oxidation-Reduction
1
2022
1033
0.150
 Why?
Accelerometry
2
2019
93
0.140
 Why?
Cellular Senescence
1
2019
181
0.140
 Why?
Cross-Sectional Studies
4
2019
5066
0.140
 Why?
Physician Assistants
1
2019
89
0.140
 Why?
Weight-Bearing
1
2018
162
0.140
 Why?
Attitude to Health
2
2014
431
0.140
 Why?
Allergens
1
2020
385
0.130
 Why?
Germany
1
2017
100
0.130
 Why?
Nurse Practitioners
1
2019
132
0.130
 Why?
Perception
1
2019
339
0.130
 Why?
Sulfonamides
2
2010
496
0.130
 Why?
Nurses
1
2019
164
0.130
 Why?
Common Variable Immunodeficiency
1
2016
27
0.130
 Why?
Antihypertensive Agents
2
2010
485
0.130
 Why?
Medicare
2
2018
720
0.130
 Why?
Tidal Volume
1
2016
84
0.130
 Why?
Host-Pathogen Interactions
1
2019
352
0.130
 Why?
Clinical Trials as Topic
3
2024
1004
0.130
 Why?
Granuloma
1
2016
89
0.130
 Why?
Cyclophosphamide
1
2016
232
0.130
 Why?
Muscle Strength
2
2015
303
0.120
 Why?
Health Policy
1
2018
353
0.120
 Why?
Interviews as Topic
2
2016
717
0.120
 Why?
Physical Conditioning, Human
1
2015
39
0.120
 Why?
Rituximab
1
2016
164
0.120
 Why?
Neuroendocrine Cells
1
2015
32
0.120
 Why?
Recovery of Function
1
2018
642
0.120
 Why?
Geographic Information Systems
1
2014
42
0.110
 Why?
Case-Control Studies
4
2019
3381
0.110
 Why?
Nitric Oxide
1
2020
902
0.110
 Why?
Societies, Medical
5
2020
751
0.110
 Why?
Enzyme Inhibitors
2
2016
827
0.110
 Why?
Sarcoidosis, Pulmonary
1
2015
83
0.110
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.110
 Why?
Sildenafil Citrate
1
2013
59
0.110
 Why?
Information Dissemination
1
2016
205
0.110
 Why?
Antifibrinolytic Agents
1
2014
47
0.110
 Why?
Carbon Monoxide
3
2019
68
0.110
 Why?
Predictive Value of Tests
3
2024
1952
0.100
 Why?
Sulfones
1
2013
108
0.100
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
37
0.100
 Why?
Endpoint Determination
1
2013
76
0.100
 Why?
Phenotype
2
2018
3076
0.100
 Why?
Antibiotics, Antineoplastic
1
2013
123
0.100
 Why?
Smoking
3
2019
1501
0.100
 Why?
Practice Guidelines as Topic
1
2020
1501
0.100
 Why?
Patient Dropouts
1
2013
64
0.100
 Why?
Self Report
2
2019
799
0.100
 Why?
Purines
1
2013
172
0.100
 Why?
Adaptation, Psychological
1
2017
616
0.100
 Why?
Occupational Exposure
1
2016
299
0.100
 Why?
Pulmonary Gas Exchange
1
2012
120
0.100
 Why?
Histocompatibility Antigens Class II
1
2013
362
0.100
 Why?
Vasodilator Agents
1
2013
326
0.090
 Why?
Health Care Surveys
1
2014
559
0.090
 Why?
Minnesota
1
2012
149
0.090
 Why?
Dust
1
2012
94
0.090
 Why?
Delivery of Health Care
1
2018
893
0.090
 Why?
Clinical Competence
1
2019
1016
0.090
 Why?
United Kingdom
1
2012
258
0.090
 Why?
Piperazines
1
2013
342
0.090
 Why?
Young Adult
5
2017
12426
0.090
 Why?
Fear
1
2014
350
0.090
 Why?
Hydrogen-Ion Concentration
1
2012
544
0.090
 Why?
Epidemiologic Methods
1
2010
74
0.090
 Why?
Anti-Infective Agents
1
2013
248
0.090
 Why?
Health Surveys
1
2012
494
0.080
 Why?
Pilot Projects
2
2015
1587
0.080
 Why?
Sickness Impact Profile
2
2009
55
0.080
 Why?
Salivary Glands, Minor
1
2009
9
0.080
 Why?
Sjogren's Syndrome
1
2009
48
0.080
 Why?
International Cooperation
3
2015
174
0.080
 Why?
Hyperplasia
2
2015
171
0.080
 Why?
Oximetry
1
2009
87
0.080
 Why?
Risk
1
2011
854
0.080
 Why?
Scleroderma, Limited
1
2008
5
0.070
 Why?
Europe
3
2015
364
0.070
 Why?
Poisson Distribution
3
2016
73
0.070
 Why?
Sleep Wake Disorders
1
2011
252
0.070
 Why?
Cardiac Catheterization
1
2011
518
0.070
 Why?
Radiography
2
2016
798
0.070
 Why?
Wound Healing
1
2010
305
0.070
 Why?
Depression
2
2019
1307
0.070
 Why?
Comorbidity
2
2017
1547
0.070
 Why?
Models, Statistical
1
2011
623
0.070
 Why?
Pericardium
1
2007
54
0.070
 Why?
Clinical Trials, Phase III as Topic
2
2016
93
0.060
 Why?
Seasons
1
2008
502
0.060
 Why?
Medical Records
1
2006
171
0.060
 Why?
Regression Analysis
3
2016
993
0.060
 Why?
Singapore
1
2024
20
0.060
 Why?
California
1
2005
401
0.060
 Why?
Echocardiography
1
2007
629
0.050
 Why?
Bronchoscopy
1
2025
216
0.050
 Why?
Acute Disease
1
2006
980
0.050
 Why?
Dose-Response Relationship, Drug
2
2020
2012
0.050
 Why?
Data Interpretation, Statistical
2
2018
335
0.050
 Why?
National Institutes of Health (U.S.)
1
2024
123
0.050
 Why?
ROC Curve
1
2025
503
0.050
 Why?
Terminology as Topic
1
2005
204
0.050
 Why?
Lymphoid Tissue
1
2002
67
0.050
 Why?
Whole Genome Sequencing
1
2023
130
0.050
 Why?
Rheumatologists
1
2022
15
0.050
 Why?
Exome
1
2023
220
0.050
 Why?
Age Factors
3
2019
3144
0.050
 Why?
Telomere
1
2024
232
0.050
 Why?
Lysophospholipids
1
2021
72
0.050
 Why?
Patient Care
1
2022
109
0.040
 Why?
Patient Selection
1
2005
663
0.040
 Why?
Attitude
1
2022
253
0.040
 Why?
Genomics
1
2025
716
0.040
 Why?
Adolescent
3
2017
20391
0.040
 Why?
Total Lung Capacity
1
2019
33
0.040
 Why?
Disease Models, Animal
1
2010
4063
0.040
 Why?
Occupations
1
2019
42
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
35
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
44
0.040
 Why?
GTPase-Activating Proteins
1
2019
81
0.040
 Why?
Exoribonucleases
1
2019
43
0.040
 Why?
Blood Gas Analysis
1
2019
71
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
133
0.040
 Why?
Education
1
2018
101
0.040
 Why?
Watchful Waiting
1
2018
67
0.040
 Why?
Administration, Inhalation
1
2020
666
0.040
 Why?
Telomere-Binding Proteins
1
2019
102
0.040
 Why?
DNA Helicases
1
2019
149
0.040
 Why?
Administrative Claims, Healthcare
1
2017
26
0.040
 Why?
Physical Endurance
1
2019
262
0.030
 Why?
Forecasting
1
2019
359
0.030
 Why?
Mucin-5B
1
2019
217
0.030
 Why?
Telomerase
1
2019
233
0.030
 Why?
Hypersplenism
1
2016
7
0.030
 Why?
Mass Screening
1
2024
1149
0.030
 Why?
Spirometry
1
2017
257
0.030
 Why?
Algorithms
1
2024
1622
0.030
 Why?
Leukopenia
1
2016
28
0.030
 Why?
Sequence Analysis, DNA
1
2019
779
0.030
 Why?
Banking, Personal
1
2016
2
0.030
 Why?
Social Participation
1
2016
14
0.030
 Why?
Creatine Kinase
1
2016
73
0.030
 Why?
Health Care Sector
1
2016
23
0.030
 Why?
Rheumatoid Factor
1
2017
167
0.030
 Why?
Death Certificates
1
2016
30
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
487
0.030
 Why?
Health Services Needs and Demand
1
2017
264
0.030
 Why?
Biomarkers
2
2019
3973
0.030
 Why?
Arthritis
1
2016
90
0.030
 Why?
Commerce
1
2016
67
0.030
 Why?
International Classification of Diseases
1
2016
122
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
19
0.030
 Why?
Metals
1
2016
128
0.030
 Why?
Promoter Regions, Genetic
1
2019
1207
0.030
 Why?
Anthropometry
1
2015
204
0.030
 Why?
Pandemics
1
2023
1486
0.030
 Why?
Physical Examination
1
2016
235
0.030
 Why?
Disease-Free Survival
1
2016
648
0.030
 Why?
Genetic Variation
1
2019
937
0.030
 Why?
Alberta
1
2013
14
0.030
 Why?
Bronchiolitis
1
2015
90
0.030
 Why?
Teaching
1
2016
214
0.030
 Why?
Mortality, Premature
1
2013
12
0.030
 Why?
Odds Ratio
1
2016
1023
0.030
 Why?
Adrenal Cortex Hormones
1
2016
522
0.030
 Why?
Counseling
1
2016
385
0.030
 Why?
RNA
1
2019
883
0.030
 Why?
Drug Therapy, Combination
1
2016
1040
0.030
 Why?
Genome-Wide Association Study
1
2019
1333
0.020
 Why?
Congresses as Topic
1
2013
215
0.020
 Why?
Administration, Oral
1
2014
786
0.020
 Why?
Inflammation
1
2002
2736
0.020
 Why?
Antigens, Human Platelet
1
2011
2
0.020
 Why?
Japan
1
2011
98
0.020
 Why?
Latin America
1
2011
88
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2282
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
4
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
529
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
14
0.020
 Why?
Syndrome
1
2009
341
0.020
 Why?
Animals
1
2010
35360
0.020
 Why?
Cell Proliferation
1
2015
2391
0.020
 Why?
Lymphocytes
1
2009
377
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
66
0.020
 Why?
Body Mass Index
1
2015
2273
0.020
 Why?
Risk Assessment
1
2015
3240
0.020
 Why?
Muscle, Skeletal
1
2015
1614
0.020
 Why?
Nuclear Proteins
1
2008
663
0.010
 Why?
Child
1
2002
20882
0.010
 Why?
Pneumonia
1
2008
616
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (370) concept(s)
_
Co-Authors Expand Description
See all (37) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)